Literature DB >> 8050593

Immunochemical identification and translocation of protein kinase C zeta in human neutrophils.

P M Dang1, J Hakim, A Périanin.   

Abstract

Western blots of human polymorphonuclear leukocyte (PMN) extracts were immunostained with antibodies specific for various protein kinase C (PKC) isoforms. Two bands corresponding to PKC type zeta with apparent molecular masses of 81 kDa and 76 kDa were identified in the cytosolic fraction of resting cells, in addition to PKC types alpha and beta. PKC zeta was apparently abundant, like PKC beta, whereas PKC delta, -epsilon, and -gamma were not detectable. Following short stimulation (5 min) of PMN with phorbol-12-myristate-13-acetate (1 microgram/ml), physical translocation of PKC zeta from the cytosol to the plasma membrane fraction occurred, although this isoform does not bind phorbol esters. These data show that, in addition to the two calcium-dependent isoenzymes alpha and beta, human PMN express a calcium-independent isoenzyme zeta which translocates in stimulated cells, suggesting a role in the regulation of antibacterial activities.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8050593     DOI: 10.1016/0014-5793(94)00700-4

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  13 in total

1.  Protein kinase C expression and subcellular distribution in chronic myocardial ischemia. Comparison of two different canine models.

Authors:  M Matejovicova; B Shivalkar; J Vanhaecke; M Szilard; W Flameng
Journal:  Mol Cell Biochem       Date:  1999-11       Impact factor: 3.396

2.  Protein kinases and multidrug resistance.

Authors:  M G Rumsby; L Drew; J R Warr
Journal:  Cytotechnology       Date:  1998-09       Impact factor: 2.058

3.  Cytosolic phospholipase A2 and its mode of activation in human neutrophils by opsonized zymosan. Correlation between 42/44 kDa mitogen-activated protein kinase, cytosolic phospholipase A2 and NADPH oxidase.

Authors:  I Hazan; R Dana; Y Granot; R Levy
Journal:  Biochem J       Date:  1997-09-15       Impact factor: 3.857

4.  The activation of the neutrophil respiratory burst by anti-neutrophil cytoplasm autoantibody (ANCA) from patients with systemic vasculitis requires tyrosine kinases and protein kinase C activation.

Authors:  D J Radford; J M Lord; C O Savage
Journal:  Clin Exp Immunol       Date:  1999-10       Impact factor: 4.330

5.  An apparently novel protein of human leukocytes, reactive with an antibody to protein kinase C-gamma, is rapidly modified upon cell activation: initial characterization in neutrophils and their cytoplasts.

Authors:  J I Smallwood; S E Malawista
Journal:  Inflammation       Date:  1998-02       Impact factor: 4.092

6.  Common and distinct intracellular signaling pathways in human neutrophils utilized by platelet activating factor and FMLP.

Authors:  J A Nick; N J Avdi; S K Young; C Knall; P Gerwins; G L Johnson; G S Worthen
Journal:  J Clin Invest       Date:  1997-03-01       Impact factor: 14.808

7.  An atypical protein kinase C, PKC zeta, regulates human eosinophil effector functions.

Authors:  Masahiko Kato; Takafumi Yamaguchi; Atsushi Tachibana; Masato Suzuki; Takashi Izumi; Kenichi Maruyama; Yasuhide Hayashi; Hirokazu Kimura
Journal:  Immunology       Date:  2005-10       Impact factor: 7.397

8.  Signal transduction mechanism in human neutrophil: comparative study between the zeta and beta-protein kinase isotypes.

Authors:  S Das; S Bhattacharyya; S Ghosh; S Majumdar
Journal:  Mol Cell Biochem       Date:  2000-01       Impact factor: 3.396

9.  Fungal metabolite gliotoxin inhibits assembly of the human respiratory burst NADPH oxidase.

Authors:  Shohko Tsunawaki; Lucia S Yoshida; Satoshi Nishida; Toshihiro Kobayashi; Takashi Shimoyama
Journal:  Infect Immun       Date:  2004-06       Impact factor: 3.441

10.  Regulation of TNF-induced oxygen radical production in human neutrophils: role of delta-PKC.

Authors:  Laurie E Kilpatrick; Shuang Sun; Haiying Li; Thomas C Vary; Helen M Korchak
Journal:  J Leukoc Biol       Date:  2009-10-02       Impact factor: 4.962

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.